Point72 Asset Management Portfolio holdings
AUM
$42.3B
1-Year Return
23.07%
This Quarter Return
+11.82%
1 Year Return
+23.07%
3 Year Return
+96.14%
5 Year Return
+182.48%
10 Year Return
+383.75%
AUM
$33B
AUM Growth
+$3.68B
(+13%)
Cap. Flow
-$46.1M
Cap. Flow
% of AUM
-0.14%
Top 10 Holdings %
Top 10 Hldgs %
9.78%
Holding
2,289
New
411
Increased
470
Reduced
375
Closed
792
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$263M |
| 2 |
Oracle
ORCL
|
+$230M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$225M |
| 4 |
RH
RH
|
+$174M |
| 5 |
Evergy
EVRG
|
+$172M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$590M |
| 2 |
NVIDIA
NVDA
|
+$539M |
| 3 |
Boeing
BA
|
+$266M |
| 4 |
Intel
INTC
|
+$208M |
| 5 |
Arista Networks
ANET
|
+$206M |
Sector Composition
| 1 | Healthcare | 18.68% |
| 2 | Technology | 17.01% |
| 3 | Consumer Discretionary | 13.87% |
| 4 | Industrials | 13.32% |
| 5 | Energy | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDRX
451
DELISTED
Veradigm Inc. Common Stock
MDRX
| $15.3M | 0.04% |
1,454,470
-2,311,130
| -61% | -$24.2M |
|
452
Pinnacle West Capital
PNW
$10.5B
| $15.2M | 0.04% |
211,700
-196,342
| -48% | -$14.1M |
|
453
Dillards
DDS
$8.88B
| $15.2M | 0.04% |
37,600
+22,344
| +146% | +$9.02M |
|
454
Vera Therapeutics
VERA
$1.55B
| $15.1M | 0.04% |
+984,324
| New | +$15.1M |
|
455
Akero Therapeutics
AKRO
$3.46B
| $15M | 0.04% |
644,305
+605,705
| +1,569% | +$14.1M |
|
456
Flowserve
FLS
$7.35B
| $15M | 0.04% |
363,900
+105,501
| +41% | +$4.35M |
|
457
Ventas
VTR
$31.5B
| $15M | 0.04% |
300,545
-28,073
| -9% | -$1.4M |
|
458
Crane Co
CR
$10.5B
| $15M | 0.04% |
126,645
+8,357
| +7% | +$987K |
|
459
Dorian LPG
LPG
$1.35B
| $14.8M | 0.04% |
337,600
+336,200
| +24,014% | +$14.7M |
|
460
Arcus Biosciences
RCUS
$1.25B
| $14.7M | 0.04% |
768,750
+764,293
| +17,148% | +$14.6M |
|
|
CNTA
461
Centessa Pharmaceuticals
CNTA
$3.04B
| $14.7M | 0.04% |
1,840,482
| – | – |
|
462
Nova
NVMI
$8.25B
| $14.6M | 0.04% |
106,300
-37,200
| -26% | -$5.11M |
|
463
Recursion Pharmaceuticals
RXRX
$1.98B
| $14.5M | 0.04% |
1,470,200
+1,332,700
| +969% | +$13.1M |
|
464
Accenture
ACN
$151B
| $14.4M | 0.03% |
+40,985
| New | +$14.4M |
|
465
CoStar Group
CSGP
$36.6B
| $14.2M | 0.03% |
162,000
+88,800
| +121% | +$7.76M |
|
466
Mastercard
MA
$524B
| $14.2M | 0.03% |
33,178
-112,601
| -77% | -$48M |
|
467
PNC Financial Services
PNC
$79.5B
| $14.1M | 0.03% |
+91,231
| New | +$14.1M |
|
|
SPWR
468
DELISTED
SunPower Corporation Common Stock
SPWR
| $14.1M | 0.03% |
2,910,930
+2,834,362
| +3,702% | +$13.7M |
|
469
Consumer Discretionary Select Sector SPDR Fund
XLY
$23.6B
| $14M | 0.03% |
78,457
+76,457
| +3,823% | +$13.7M |
|
|
HPP
470
Hudson Pacific Properties
HPP
$1.1B
| $14M | 0.03% |
1,506,626
-568,274
| -27% | -$5.29M |
|
471
Altimmune
ALT
$324M
| $14M | 0.03% |
+1,246,500
| New | +$14M |
|
472
Home Depot
HD
$411B
| $14M | 0.03% |
40,362
+36,133
| +854% | +$12.5M |
|
473
Hancock Whitney
HWC
$5.35B
| $13.9M | 0.03% |
286,475
+285,661
| +35,093% | +$13.9M |
|
474
Vishay Intertechnology
VSH
$2.07B
| $13.9M | 0.03% |
579,800
+489,200
| +540% | +$11.7M |
|
475
Kinross Gold
KGC
$28B
| $13.8M | 0.03% |
2,288,570
+2,211,242
| +2,860% | +$13.4M |
|